GelStat Corp. (OTCMKTS:GSAC) Short Interest Up ? in May

GelStat Corp. (OTCMKTS:GSAC) was the recipient of a significant increase in short interest during the month of May. As of May 29th, there was short interest totaling 100,000 shares, an increase of ? from the May 14th total of 0 shares. Based on an average trading volume of 7,458,359 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

GelStat Price Performance

Shares of GSAC remained flat at $0.00 during trading hours on Monday. The stock had a trading volume of 3,749 shares, compared to its average volume of 1,679,876. GelStat has a 12-month low of $0.00 and a 12-month high of $0.00.

GelStat Company Profile

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers.